ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed
Rong‐Guang Shao
Matched on ORCID iD 0000-0002-2382-6978; OpenAlex author ID A5002650576. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 13
2019: 1 paper · 2020: none · 2021: none · 2022: 3 papers · 2023: 1 paper
Papers 5
- Miriplatin-loaded liposome, as a novel mitophagy inducer, suppresses pancreatic cancer proliferation through blocking POLG and TFAM-mediated mtDNA replication. Co-author DOI 10.1016/j.apsb.2023.07.009↗
- The novel ER stress inducer Sec C triggers apoptosis by sulfating ER cysteine residues and degrading YAP via ER stress in pancreatic cancer cells. Last author DOI 10.1016/j.apsb.2021.07.004↗
- An EGFR/HER2-targeted conjugate sensitizes gemcitabine-sensitive and resistant pancreatic cancer through different SMAD4-mediated mechanisms. Co-author DOI 10.1038/s41467-022-33037-x↗
- YOD1 serves as a potential prognostic biomarker for pancreatic cancer. Last author DOI 10.1186/s12935-022-02616-9↗
- Internal enhancement of DNA damage by a novel bispecific antibody-drug conjugate-like therapeutics via blockage of mTOR and PD-L1 signal pathways in pancreatic… Last author DOI 10.1002/cam4.1974↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Wuli Zhao · 2 shared papers, 2022–2023 · strength 0.36
- Paper Miriplatin-loaded liposome, as a novel mitophagy inducer, suppresses pancreatic cancer proliferation through blocking P… DOI 10.1016/j.apsb.2023.07.009↗
- Paper The novel ER stress inducer Sec C triggers apoptosis by sulfating ER cysteine residues and degrading YAP via ER stress … DOI 10.1016/j.apsb.2021.07.004↗
- Hong-Juan Yao · 2 shared papers, 2019–2022 · strength 0.23
- Paper An EGFR/HER2-targeted conjugate sensitizes gemcitabine-sensitive and resistant pancreatic cancer through different SMAD… DOI 10.1038/s41467-022-33037-x↗
- Paper Internal enhancement of DNA damage by a novel bispecific antibody-drug conjugate-like therapeutics via blockage of mTOR… DOI 10.1002/cam4.1974↗
- Rui Cao · 2 shared papers, 2019–2022 · strength 0.23
- Paper An EGFR/HER2-targeted conjugate sensitizes gemcitabine-sensitive and resistant pancreatic cancer through different SMAD… DOI 10.1038/s41467-022-33037-x↗
- Paper Internal enhancement of DNA damage by a novel bispecific antibody-drug conjugate-like therapeutics via blockage of mTOR… DOI 10.1002/cam4.1974↗
- Liang Li · 2 shared papers, 2019–2022 · strength 0.23
- Paper An EGFR/HER2-targeted conjugate sensitizes gemcitabine-sensitive and resistant pancreatic cancer through different SMAD… DOI 10.1038/s41467-022-33037-x↗
- Paper Internal enhancement of DNA damage by a novel bispecific antibody-drug conjugate-like therapeutics via blockage of mTOR… DOI 10.1002/cam4.1974↗
- Guimin Xia · 1 shared paper, 2023 · strength 0.22
- Xiaowei Wang · 1 shared paper, 2023 · strength 0.22
- Zhishuo Zhang · 1 shared paper, 2022 · strength 0.16
- Junxia Wang · 1 shared paper, 2022 · strength 0.14
- Yuchen Shi · 1 shared paper, 2022 · strength 0.13
- Xiaofei Zhou · 1 shared paper, 2022 · strength 0.13
- Hebing Chen · 1 shared paper, 2022 · strength 0.13
- Yi Li · 1 shared paper, 2022 · strength 0.13
- Li Zhang · 1 shared paper, 2022 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.